Broncos LB Alex Singleton says cancerous tumor successfully removed


Broncos linebacker Alex Singleton gets ready for the snap during a game against the Eagles in October.

Alex Singleton said he expects to be back on the field in the coming weeks after surgery for testicular cancer on Friday. Eric Hartline / Imagn Images

Denver Broncos linebacker Alex Singleton was recently diagnosed with testicular cancer and had surgery to remove a tumor on Friday, he said in a social media post Monday.

The 31-year-old veteran played all 60 of Denverโ€™s snaps in last Thursdayโ€™s 10-7 victory against the Raiders, the night before the operation. He said he believes โ€œthe cancer was caught early with a great prognosis for me and my family.โ€

Singleton told the team about his diagnosis on Monday morning and said in his post, โ€œWhile we are still awaiting some additional test results, I fully expect to return to the field in the coming weeks.โ€

Singleton said he was randomly selected a little more than two weeks ago to be tested under the leagueโ€™s drug testing program. He received notice following the test that he had elevated levels of the hormone hCG in his system.

โ€œWithout a doubt, I knew how diligent I am with what goes into my body that this was not from anything external I may have taken,โ€ Singleton said. โ€œAfter speaking with my agent and wife, we decided to book an appointment with a urologist.โ€

Singleton found out one week ago, three days before the game against the Raiders, that he had signs of testicular cancer and an ultrasound later confirmed the diagnosis.

โ€œOur No. 1 priority is Alexโ€™s health and well-being,โ€ the Broncos said in a statement, โ€œand we are grateful it appears the cancer was caught early. Alex and his family have our unwavering support as we look forward to welcoming him back on the field soon.โ€

Connections: Sports Edition Logo

Connections: Sports Edition Logo

Connections: Sports Edition

Spot the pattern. Connect the terms

Find the hidden link between sports terms



Leave comment

Your email address will not be published. Required fields are marked with *.